$KRYS 8-K SEC Filings

Filed On	Filing
15 Oct 2026	8-K: Regulation FD Disclosure Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113
03 Aug 2026	8-K: Results of Operations and Financial Condition
21 Jul 2026	8-K: Other Events
20 May 2026	8-K: Submission of Matters to a Vote of Security Holders
04 May 2026	8-K: Financial Statements and Exhibits
17 Feb 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
08 Jan 2026	8-K: Regulation FD Disclosure
23 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
03 Nov 2025	8-K: Results of Operations and Financial Condition
22 Oct 2025	8-K: Other Events
04 Aug 2025	8-K: Results of Operations and Financial Condition
25 Jul 2025	8-K: Regulation FD Disclosure
24 Jul 2025	8-K: Regulation FD Disclosure
09 Jul 2025	8-K: Regulation FD Disclosure
02 Jun 2025	8-K: Other Events
19 May 2025	8-K: Submission of Matters to a Vote of Security Holders
13 May 2025	8-K: Regulation FD Disclosure
06 May 2025	8-K: Results of Operations and Financial Condition
06 May 2025	8-K: Regulation FD Disclosure

Comments